Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin target attainment in general ward patients
NL-OMON44298Not yet recruiting
- Sponsor
- Academic Medical Center
- Start
- Jan 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ciprofloxacin in bacterial disease, sponsored by Academic Medical Center. Primary endpoint: Primary PK/PD target attainment. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
ciprofloxacin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on NL-OMON44298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44298.